We are a leader in protecting the health and safety of our employees and neighbours, and our operations continually exceed the standards set by the Canadian Nuclear Safety Commission (CNSC). Meeting or exceeding the CNSC requirements, we do our part to protect the health, safety, environment and security of Canadians. And, through our Public Information Program (PIP), we are committed to open public communications.
Public Information Program (PIP)
Public Disclosure Protocol
Our Public Information Program (PIP) is designed to ensure that information related to the health, safety and security of persons and the environment – and other issues associated with the lifecycle of our nuclear facility – are effectively communicated to those of you who live in our community.The PIP relates to CNSC-licensed activities of our Ottawa facility and includes a commitment to and a protocol for ongoing, timely communications.
Public Disclosure 2018
Storm of Friday, September 21, 2018 – No Impact on Nordion
A significant storm passed through the Ottawa area Friday night with tornados touching down in several communities. Nordion personnel were closely monitoring the facility during this time. We are happy to report that the Nordion facility was not impacted by the storm. The Nordion facility remained fully powered, operational, and safe during the storm and throughout the weekend.
Nordion Volunteers plant shrubs along the Nordion side of the creek (Kizell Drain)
On May 28, Nordion volunteers, along with a few members of the Mississippi Conservation Authority, successfully planted several hundred shrubs along the Nordion side of the creek (Kizell Drain) that crosses Nordion’s property. These shrubs will help reduce erosion of the shore banks.
Nordion is selling an unneeded office building and some surplus land
Kanata residents may have noticed a sign at Nordion’s campus advertising the sale of Nordion’s five storey office building and some surplus land along March Road. During the 1960s, Nordion was one of the first technology operations to buy business property in an area which, at the time, was still part of the farmlands of March Township.
Since then, Kanata has grown into a major technology hub with high demand for property along March Road. As part of our ongoing planning processes, Nordion regularly reviews its current and future property and office space needs, and recently concluded that it no longer made sense to retain the five storey office building and surplus lands. Following the sale of the building Nordion will continue to own a sizable campus in the Kanata North business Area including its two storey building which has ample space to accommodate current operations as well as planned and unplanned future growth.
CNSC On-Site May 29th and 30th Conducting Routine Environmental Sampling
The CNSC will be on the Nordion site May 29th and 30th conducting routine environmental sampling as part of their Independent Environmental Monitoring Program (IEMP). To complement existing and ongoing compliance activities, the CNSC implements its Independent Environmental Monitoring Program (IEMP) to verify that the public and environment around CNSC-regulated nuclear facilities are not adversely affected by releases to the environment. The CNSC last conducted independent environmental monitoring at Nordion in 2016.
For more information on the CNSC’s Independent Environmental Monitoring Program (IEMP) please see Independent Environmental Monitoring Program (IEMP)
Sotera Health LLC announces intent to sell Nordion’s Medical Isotopes segment to BWXT
Sotera Health committed to Safeguarding Global HealthTM with Nordion’s increased focus on global gamma technologies business
BROADVIEW HEIGHTS, OH – April 17, 2018 –Sotera Health LLC, the world’s leading, fully integrated protector of global health, today announced that it has entered into a definitive asset purchase agreement to sell the Medical Isotopes segment of its Nordion business to a subsidiary of BWX Technologies, Inc. (BWXT). This transaction will create a platform that will accelerate growth for both companies.
“The world’s need for gamma technology has expanded dramatically as the demand for sterilization of medical and non-medical applications has accelerated in response to increasing global regulatory demands and growing healthcare needs” said Michael Petras, Chief Executive Officer of Sotera Health. “The sale will enable BWXT to enter the medical isotope field with highly skilled employees and specialized facilities that are recognized as the best in the business. As the world’s only fully integrated provider of mission-critical services to the healthcare industry, Sotera Health is excited about the additional value Nordion will bring to
our gamma customers, and our other best-in-class businesses, Sterigenics and Nelson Labs.”
Through the agreement, BWXT will acquire essentially all of Nordion’s medical isotope assets, including the radiochemical operation and contract manufacturing services in Kanata, and the medical isotope operation in Vancouver, British Columbia.
Both companies will continue to operate from Nordion’s state-of-the-art licensed facility in Kanata, Ontario. Approximately 150 employees will transition to BWXT at the close of the sale.
“Nordion will continue to focus on accelerating growth in gamma technologies, including industrial and medical cobalt-60 which fits perfectly with Sotera Health’s broader mission of Safeguarding Global Health™,” said Kevin Brooks, President of Nordion.
About Sotera Health:
Sotera Health LLC, along with its business entities, is the world’s leading, fully integrated protector of global health. With over 500 years of combined scientific expertise, the company ensures the safety of healthcare by providing mission-critical services to the medical device, pharmaceutical, tissue and food industries. Sotera Health operates more than 61 facilities in 13 countries. The company has over 2,600 employees globally and touches the lives of more than 180 million people around the world each year. Sotera Health serves more than 5,000 customers worldwide including 75 of the top 100 medical device manufacturers.
Sotera Health goes to market through its three best-in-class companies – Nelson Labs™,
Nordion® and Sterigenics® – with the mission of ensuring the safety of healthcare each and every day. Nelson Labs offers microbiological and analytical testing and consultancy to assist customers in developing and maintaining sterilization solutions in medical devices, tissue/implantable products, and the pharmaceutical and biologics fields. Nordion is the world’s largest provider of Cobalt-60 used in the gamma sterilization process as well as medical isotopes used in the diagnosis and treatment of various diseases and cancers. Sterigenics provides comprehensive contract sterilization and ionization solutions for the medical device, pharmaceutical, food safety and high-performance materials industries.
Sotera Health LLC is owned by private equity firms Warburg Pincus and GTCR. Learn more about Sotera Health at soterahealth.com, about Nelson Labs at nelsonlabs.com, about Nordion at nordion.com and about Sterigenics at sterigenics.com.
Contacts:
Paul Monlezun
Public Affairs Advisors
613-222-7184
paul.monlezun@publicaffairsadvisors.com
Kristin A. Gibbs
Chief Marketing Officer
Sotera Health LLC
kgibbs@soterahealth.com
440-262-1412